100
Participants
Start Date
January 5, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Batoclimab
Batoclimab is a fully human anti-neonatal fragment crystallizable receptor (FcRn) monoclonal antibody
Placebo
Matching Placebo
Site Number - 4672, Brussels
Site Number - 7550, Budapest
Site Number - 4673, Brussels
Site Number - 7565, Sydney
Site Number - 7572, Hamilton
Site Number - 4674, Liège
Site Number - 4950, Ankara
Site Number - 7551, Pécs
Site Number - 7552, Pécs
Site Number -4671, Bruges
Site Number - 7570, Christchurch
Site Number - 4952, Adana
Site Number -3600, Santiago de Compostela
Site Number -1511, Morgantown
Site Number - 1512, Winston-Salem
Site Number -3601, Madrid
Site Number -3604, Madrid
Site Number - 4951, Istanbul
Site Number -1510, Sarasota
Site Number -1516, Louisville
Site Number -3606, Seville
Site Number -3603, Valencia
Site Number - 1526, Livonia
Site Number - 1518, Milwaukee
Site Number - 6603, Mainz
Site Number - 1513, Rochester
Site Number -1515, Bellaire
Site Number -1519, San Antonio
Site Number - 1524, McAllen
Site Number - 9203, Bratislava
Site Number - 9200, Bratislava
Site Number - 9201, Bratislava
Site Number -1514, Torrance
Site Number - 9202, Trenčín
Site Number -1520, Pasadena
Site Number -1517, San Francisco
Site Number - 1525, Portland
Site Number - 1521, Seattle
Site Number -4670, Ghent
Site Number -9301, Ogre
Site Number -9300, Riga
Site Number - 9302, Ventspils
Site Number -1990, San Juan
Site Number -3602, Barcelona
Site Number - 3605, Barcelona
Lead Sponsor
Immunovant Sciences GmbH
INDUSTRY